XML 58 R25.htm IDEA: XBRL DOCUMENT v3.19.3
NET LOSS PER SHARE
 6 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
NET LOSS PER SHARE NET LOSS PER SHARE
Calculations of the basic and diluted net loss per share and potential common shares are as follows (in thousands, except for per share data):

Three Months Ended

Six Months Ended
 
September 30,

September 30,
 
2019

2018

2019

2018
Numerator:







Net loss
$
(17,472
)
 
$
(26,428
)
 
$
(46,815
)
 
$
(88,932
)
Denominator:
 
 
 
 
 
 
 
Denominator for basic net loss per share - weighted average common shares outstanding
75,687

 
78,631

 
76,490

 
79,490

Dilutive common equivalent shares:
 
 
 
 
 
 
 
      Weighted average restricted stock units
—

 
—

 
—

 
—

Denominator for diluted net loss per share - weighted average shares outstanding
75,687

 
78,631

 
76,490

 
79,490

Net loss per share:
 
 
 
 
 
 
 
Basic net loss per share
$
(0.23
)
 
$
(0.34
)
 
$
(0.61
)
 
$
(1.12
)
Diluted net loss per share
$
(0.23
)
 
$
(0.34
)
 
$
(0.61
)
 
$
(1.12
)

The following table sets forth restricted stock units excluded from the calculation of diluted net loss per share, since their inclusion would be anti-dilutive (in thousands):

Three Months Ended

Six Months Ended
 
September 30,

September 30,
 
2019

2018

2019

2018
Restricted stock units
624

 
731

 
897

 
895


Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during the period. Unvested restricted shares, although legally issued and outstanding, are not considered outstanding for purposes of calculating basic earnings per share. Diluted net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding plus the dilutive effect, if any, of outstanding stock options, restricted shares and restricted stock units using the treasury stock method. The calculation of the dilutive effect of outstanding equity awards under the treasury stock method includes consideration of proceeds from the assumed exercise of stock options and unrecognized compensation expense as additional proceeds. As we incurred a net loss during the three and six months ended September 30, 2019 and 2018, all outstanding restricted stock units have an anti-dilutive effect and are therefore excluded from the computation of diluted weighted average shares outstanding.
The delivery of approximately 7.4 million shares under the Company's accelerated share repurchase (ASR) agreements reduced our outstanding shares used to determine our weighted average common shares outstanding for purposes of calculating basic and diluted earnings per share for the six months ended September 30, 2018. See Note 16 for additional information. We evaluated the ASR agreements for potential dilutive effects of any shares remaining to be received or owed upon settlement and
determined the additional shares to be received would be anti-dilutive, and therefore they were not included in our calculation of diluted earnings per share for the six months ended September 30, 2018.